Published in Int J Cancer on July 18, 2016
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet (2010) 11.00
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage (2008) 10.99
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med (2006) 10.95
Prospective study of alcohol consumption and risk of coronary disease in men. Lancet (1991) 8.64
The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health (1997) 8.00
EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis (2003) 7.95
Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA (2000) 6.54
Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA (2008) 5.27
C-reactive protein and the risk of incident colorectal cancer. JAMA (2004) 4.94
Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin (2006) 2.69
Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage (2003) 1.79
NF-kappaB signaling pathway, inflammation and colorectal cancer. Cell Mol Immunol (2009) 1.79
Prospective study of urinary prostaglandin E2 metabolite and colorectal cancer risk. J Clin Oncol (2006) 1.62
Changes in herb and dietary supplement use in the U.S. adult population: a comparison of the 2002 and 2007 National Health Interview Surveys. Clin Ther (2011) 1.61
Interleukin-1beta down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: influence of glucosamine on interleukin-1beta-mediated effects in rat chondrocytes. Arthritis Rheum (2001) 1.35
Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage (2008) 1.30
Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats. Arthritis Res Ther (2003) 1.29
Associations of herbal and specialty supplements with lung and colorectal cancer risk in the VITamins and Lifestyle study. Cancer Epidemiol Biomarkers Prev (2009) 1.14
Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats. Inflamm Res (2005) 1.10
Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis. Drugs Aging (2007) 1.07
Effects of glucosamine hydrochloride on the production of prostaglandin E2, nitric oxide and metalloproteases by chondrocytes and synoviocytes in osteoarthritis. Clin Exp Rheumatol (2004) 1.00
Chondroitin sulfate extracted from the Styela clava tunic suppresses TNF-alpha-induced expression of inflammatory factors, VCAM-1 and iNOS by blocking Akt/NF-kappaB signal in JB6 cells. Cancer Lett (2008) 0.97
Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin-1beta, matrix metalloprotease-9, and cartilage damage in arthritis. Exp Biol Med (Maywood) (2005) 0.94
Chondroitin for osteoarthritis. Cochrane Database Syst Rev (2015) 0.94
Association between use of specialty dietary supplements and C-reactive protein concentrations. Am J Epidemiol (2012) 0.93
Effect of glucosamine and related compounds on the degranulation of mast cells and ear swelling induced by dinitrofluorobenzene in mice. Life Sci (2010) 0.89
Suppressive effects of N-acetyl-D-glucosamine on rheumatoid arthritis mouse models. Inflammation (2012) 0.89
Effects of chondroitin sulfate on colitis induced by dextran sulfate sodium in rats. Jpn J Pharmacol (2001) 0.86
Glucosamine suppresses interleukin-8 production and ICAM-1 expression by TNF-alpha-stimulated human colonic epithelial HT-29 cells. Int J Mol Med (2008) 0.85
Effect of a high dose of glucosamine on systemic and tissue inflammation in an experimental model of atherosclerosis aggravated by chronic arthritis. Am J Physiol Heart Circ Physiol (2009) 0.84
Glucosamine, a naturally occurring amino monosaccharide, suppresses dextran sulfate sodium-induced colitis in rats. Int J Mol Med (2008) 0.84
Glucosamine regulation of LPS-mediated inflammation in human bronchial epithelial cells. Eur J Pharmacol (2010) 0.83
Effects of dietary supplementation of glucosamine sulfate on intestinal inflammation in a mouse model of experimental colitis. J Gastroenterol Hepatol (2014) 0.82
Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans. PLoS One (2015) 0.80
The effectiveness of Echinacea extract or composite glucosamine, chondroitin and methyl sulfonyl methane supplements on acute and chronic rheumatoid arthritis rat model. Toxicol Ind Health (2011) 0.80
Use of glucosamine and chondroitin supplements and risk of colorectal cancer. Cancer Causes Control (2013) 0.78
Associations between glucosamine and chondroitin supplement use and biomarkers of systemic inflammation. J Altern Complement Med (2014) 0.78
Differential down-regulation of COX-2 and MMP-13 in human skin fibroblasts by glucosamine-hydrochloride. J Dermatol Sci (2009) 0.78
Effects of glucosamine and chondroitin sulfate on mediators of osteoarthritis in cultured equine chondrocytes stimulated by use of recombinant equine interleukin-1beta. Am J Vet Res (2005) 0.77
Periodontal disease, tooth loss and colorectal cancer risk: Results from the Nurses' Health Study. Int J Cancer (2016) 1.09
Body mass index and risk of colorectal cancer according to tumor lymphocytic infiltrate. Int J Cancer (2016) 0.81
Assessing individual risk for high-risk colorectal adenoma at first-time screening colonoscopy. Int J Cancer (2015) 0.81
Dietary glycemic and insulin scores and colorectal cancer survival by tumor molecular biomarkers. Int J Cancer (2017) 0.75
Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans. Int J Cancer (2017) 0.75